Abstract:BACKGROUND:MicroRNAs (miRNAs) exhibit essential regulatory functions related to cell growth, apoptosis, development and differentiation. Dysregulated expression of miRNAs is associated with a wide variety of human diseases. As such miRNA signatures are valuable as biomarkers for disease and for making treatment decisions. Hepatitis B virus (HBV) is a major risk factor for hepatocellular carcinoma (HCC). Here we screened for miRNAs in chronic HBV associated HCC.METHODS:To determine the miRNAs in HCC occurrence associated with HBV infection, we analyzed global miRNA expression profiles in 12 pairs of HCC and adjacent matched non-HCC tissues from HBV-positive and HBV-negative patients using microarray analyses. The microarray result was validated by real-time PCR in 32 HBV-positive and 24 HBV-negative patient HCC samples. The potential candidate target genes of the miRNAs were predicted by miRWalk software. Genes simultaneously predicted as targets by two or more miRNAs were subjected to GO and KEGG pathway analysis. The miRNA regulatory network analysis was performed using the Ingenuity Pathway Analysis (IPA) software.RESULTS:Eight miRNAs (miR-223, miR-98, miR-15b, miR-199a-5p, miR-19b, miR-22, miR-451, and miR-101) were involved in HBV-unrelated HCC, 5 miRNAs (miR-98, miR-375, miR-335, miR-199a-5p, and miR-22) were involved in HBV infection, and 7 miRNAs (miR-150, miR-342-3p, miR-663, miR-20b, miR-92a-3p, miR-376c-3p and miR-92b) were specifically altered in HBV-related HCC. Gene Ontology and KEGG analyses predict that these HBV-related HCC miRNAs are involved in the regulation of: transcription, RNA polymerase II promoter, phosphorylation of proteins through MAPK signaling pathway, focal adhesion, and actin cytoskeleton. IPA analysis also suggest that these miRNAs act on AGO2, TP53, CCND1, and 11 other genes that significantly influence HCC occurrence and HBV infection.CONCLUSION:Our data indicates that the unique 7 miRNAs expression signature could be involved in the development HBV- related HCC.

What Are the Changes in the Hotspots and Frontiers of Micrornas in Hepatocellular Carcinoma over the Past Decade?

Research Progress of MicoRNA in Molecular Targeting Treatment of Hepatocellular Carcinoma

Role of Micrornas in Hepatocellular Carcinoma.

Diagnostic Accuracy of Circulating Micrornas for Hepatitis C Virus-Associated Hepatocellular Carcinoma: a Systematic Review and Meta-Analysis

Cross-regulation Between Micrornas and Key Proteins of Signaling Pathways in Hepatocellular Carcinoma

MicroRNAs in Hepatocellular Carcinoma: Regulation, Function, and Clinical Implications

Function and Clinical Potential of Micrornas in Hepatocellular Carcinoma

MicroRNAs Contribute to Hepatocellular Carcinoma

MicroRNAs in Hepatocellular Carcinoma: Insights into Regulatory Mechanisms, Clinical Significance, and Therapeutic Potential

The Role and Clinical Implications of Micrornas in Hepatocellular Carcinoma

Recent Advances of Mirna Involvement in Hepatocellular Carcinoma and Cholangiocarcinoma

Advances in Mirna Research in Hepatocellular Carcinoma

MicroRNA in HCC: Biomarkers and Therapeutic Targets

MicroRNA Profile in HBV-induced Infection and Hepatocellular Carcinoma.

Role of Mirna in Pathogenesis, Diagnosis, and Prognosis in Hepatocellular Carcinoma.

Diagnostic and Prognostic Implications of Micrornas in Human Hepatocellular Carcinoma

Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma

Advances in research on the role and mechanism of microRNAs in hepatic carcinogenesis

The Role of Micrornas in Liver Cancer Progression

Mirnas single nucleotide polymorphisms in the research development of hepatocellular carcinoma (HCC)

Role of miRNA in pathogenesis, diagnosis, and prognosis in hepatocellular carcinoma